UBC CPD eLearning

A biosimilar is a biologic medical product that is very similar to an original product, also known as a reference product, that is approved by FDA (Food and Drug Administration). Compared with the reference products, biosimilars are highly similar to the reference product in terms of safety, purity and potency, but with significantly reduced costs. The pressure of high healthcare costs associated with the use of biologics have created a significantly high demand for biosimilars.

Stable cell line development is one of the most important steps for biosimilar development. Creative Biogene has years of experience in stable cell line development. Our scientists have successfully expressed biologics including full antibodies, antibody fragments, bispecific antibodies, fusion proteins and growth factors. With the goal of accelerating the process of biosimilar drug development, at Creative Biogene, multiple biosimilar stable cell lines have been developed and have shown high performance in yield. In addition, more biosimilar stable cell lines are under development and will be available for sale soon.